Showing results (561-570 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|September 7, 2012
Safety profile and bleeding risk of ticagrelor compared with clopidogrelChristopher H May, A Michael LincoffExpert Opinion on Drug Safety|July 28, 2020
Safety considerations with targeted therapy drugs for B-cell non-Hodgkin lymphomaShinichi Makita, Rika Hosoba, Kensei TobinaiExpert Opinion on Drug Safety|July 15, 2020
Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilanceInyoung Lee, Todd A Lee, Stephanie Y Crawford, et al.Expert Opinion on Drug Safety|August 4, 2020
Is the lack of evidence in older adults with cancer compromising safety?Darryl Outlaw, Grant R WilliamsExpert Opinion on Drug Safety|April 15, 2022
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challengesGiordano Novak Rossi, Jaime E C Hallak, José Carlos Bouso Saiz, et al.Expert Opinion on Drug Safety|April 15, 2022
Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatmentMarcus A Doyle, Susan Ling, Leanna M W Lui, et al.Expert Opinion on Drug Safety|June 12, 2014
A comparison of disproportionality analysis methods in national adverse drug reaction databases of ChinaYongfang Hou, Xiaofei Ye, Guizhi Wu, et al.Expert Opinion on Drug Safety|May 22, 2014
On the clinical evidence leading to tetrazepam withdrawalBeatriz Proy-Vega, Carmelo Aguirre, Piet de Groot, et al.Expert Opinion on Drug Safety|May 22, 2014
Efficacy of antidepressant medications in children and adolescents with non-obsessive-compulsive disorder anxiety disorders: a systematic assessmentSalvatore GentileExpert Opinion on Drug Safety|June 17, 2014
Does the use of lapatinib increase the risk of fatigue and hepatic toxicities in patients with solid tumors? A critical literature review and meta-analysisOmar Abdel-Rahman, Mona FouadPageof 282